Seaport will use the funds for its neuropsychiatric drug pipeline, while Hemab will focus on bleeding disorder medicines.

Merck KGaA and Remepy will work in tandem to develop drug-digital therapy combinations for a rare cancer indication.

BioMarin Pharmaceutical has completed its acquisition of Amicus Therapeutics, buying the company for $14.50 per share in an all-cash deal.

AstraZeneca has received approval from the FDA for the subcutaneous self-administration of Saphnelo using the Saphnelo pen for SLE.

Sun Pharma has signed a definitive agreement to acquire Organon in a transaction with an enterprise valuation of $11.75bn in cash.

AI capabilities within pharma are evolving from add-on to an arm of core business demanding overhauled AI governance.

With an uptick and increasingly even spread of capital across the space, the BIA’s Martin Turner is optimistic for British biotech’s future.

Ajax’s lead asset is AJ1-11095, a once-daily Type II JAK2 inhibitor taken orally, which is currently in a Phase I trial.

Bowel cancer, also known as colorectal cancer, is the second most lethal cancer after lung cancer, with the highest incidence rates being reported in developed countries. Accordin ...

Pharmaceutical trade associations across the Nordic region have reacted with vigilance to a recent GlobalData report that highlighted the potential effect on product launch and withdrawal trends in ...

Novartis has secured a pair of regulatory wins from the European Commission and World Health Organization. Credit: OleksSH/Shutterstock.com. Novartis has netted a pair of regulatory wins, winning ...

AI tools that slash time spent on administration prove their worth and free up pharma workers for higher value tasks.